Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Cash from Financing Activities (2016 - 2025)

CorMedix has reported Cash from Financing Activities over the past 13 years, most recently at -$1.4 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$1.4 million for Q4 2025, down 112.52% from a year ago — trailing twelve months through Dec 2025 was $238.5 million (up 806.01% YoY), and the annual figure for FY2025 was $238.5 million, up 806.01%.
  • Cash from Financing Activities reached -$1.4 million in Q4 2025 per CRMD's latest filing, down from $150.5 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $150.5 million in Q3 2025 and bottomed at -$1.4 million in Q4 2025.
  • Median Cash from Financing Activities over the past 5 years was $6.1 million (2022), compared with a mean of $21.1 million.
  • The largest annual shift saw Cash from Financing Activities soared 9710.09% in 2023 before it tumbled 112.52% in 2025.
  • Over 5 years, Cash from Financing Activities stood at $176992.0 in 2021, then surged by 3315.74% to $6.0 million in 2022, then crashed by 92.26% to $467650.0 in 2023, then soared by 2313.18% to $11.3 million in 2024, then crashed by 112.52% to -$1.4 million in 2025.
  • Business Quant data shows Cash from Financing Activities for CRMD at -$1.4 million in Q4 2025, $150.5 million in Q3 2025, and $83.2 million in Q2 2025.